Status of PR 934-423, a novel anticonvulsant targeted for generalized tonic/clonic seizures (new designation is FPL 12924AA).
Palmer
G C
GC
Fisons Pharmaceuticals, Rochester, NY 14603.
Harris
E W
EW
Napier
J J
JJ
Stagnitto
M L
ML
Garske
G E
GE
Griffith
R C
RC
Swinyard
E A
EA
D000081:Acetamides / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D051381:Rats; D011919:Rats, Inbred Strains; D012640:Seizures / Q000188:drug therapy
D000081:Acetamides; D000927:Anticonvulsants; C067553:remacemide